GS
CELUW icon

GTS Securities’s Celularity Inc CELUW Stock Holding History

GTS Securities’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,699
Closed -$280 – 4073
2023
Q3 		$280 Hold
18,699
– – ﹤0.01% 3880
2023
Q2 		$1.07K Buy
+18,699
New +$1.13K ﹤0.01% 1185

Other funds holding CELUW

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

GTS Securities's CELUW Position: Q4 2023 in Review

GTS Securities sold out of Celularity Inc (CELUW) in Q4 2023, closing a stake of 18,699 shares — an estimated $280 sold.

GTS Securities first reported a position in CELUW in Q2 2023 and held it in 2 quarters. The position peaked at $1.07K in Q2 2023. 17 funds tracked by Wall St. Rank hold CELUW as of Q4 2023.

  • GTS Securities reported no remaining Celularity Inc position as of Q4 2023 after selling out during the quarter.
  • GTS Securities sold 18,699 Celularity Inc shares in Q4 2023, an estimated $280.
  • GTS Securities first reported a position in Celularity Inc in Q2 2023 and held it in 2 quarters.
  • GTS Securities's Celularity Inc position peaked at $1.07K in Q2 2023.
  • 17 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2023.

Based on GTS Securities's 13F filing for Q4 2023, filed 15 Feb 2024.